newsfilter
← Latest News
GlobeNewswire·

Jasper Therapeutics Announces 1-for-30 Reverse Stock Split

REDWOOD CITY, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) ("Jasper" or the "Company"), a clinical stage biotechnology company focused on the design and development